Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03023943 · ClinicalTrials.gov registry record · NA
The Effects of IASTM and Proprioception
A NA study, sponsored by Youngstown State University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03023943: Completed NA study, sponsored by Youngstown State University.
NCT03023943 is a NA study that has completed, run by Youngstown State University. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03023943, a NA study, has completed, sponsored by Youngstown State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The research design will be single group pretest-posttest design. The subject will be instructed to position the knee joint to a position previously set by the experimenter. Intervention will be 10 minutes of GT1 instrument application at anterior thigh using sweep technique.
Primary Outcome
Proprioception will be determined by measuring the reposition error of the knee joint. The subject will be instructed to position the knee joint to a position (flexion) previously set by the experimenter at 30 degree flexion. The difference will be calculated as the reposition error. The position of the knee joint will be measure using a goniometer. An alternative is to use an App (e.g. Angle Meter) on a smart phone or an iPad for accuracy.
Interventions
- OTHER Instrument Assisted Soft Tissue Mobilization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-02-03 |
| Est. Completion | 2018-05-31 |
| Phase | NA |
What the finished NCT03023943 record still lists
NCT03023943 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Instrument Assisted Soft Tissue Mobilization is the first listed.
NCT03023943 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03023943 about?
NCT03023943 is a clinical study titled "The Effects of IASTM and Proprioception". The research design will be single group pretest-posttest design. The subject will be instructed to position the knee joint to a position previously set by the experimenter. Intervention will be 10 minutes of GT1 instrument application at anterior thigh using sweep technique.
What is the current status of trial NCT03023943?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2017-02-03. Estimated completion is 2018-05-31.
What interventions are being tested in trial NCT03023943?
The interventions under investigation include: Instrument Assisted Soft Tissue Mobilization (OTHER).
Who is sponsoring clinical trial NCT03023943?
This trial is sponsored by Youngstown State University, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03023943's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI